OKUR
OnKure Therapeutics
OKUR
OKUR
32 hedge funds and large institutions have $38.4M invested in OnKure Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $55.1M → $38.4M (-$16.8M)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Holders
32
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$323K | |
| 2 | +$117K | |
| 3 | +$80.4K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$71.3K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$58.3K |
Top Sellers
| 1 | -$490K | |
| 2 | -$83.8K | |
| 3 | -$49K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$39.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |